Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
ALCIDION GROUP LIMITED (ALC)ASX AI Signals has generated 0 signals for ALC during the last 90 days, indicating low trading activity
ALC Share Price | |
| Current Price | $0.100 |
| 52 Week High | $0.140 |
| 52 Week Low: | $0.088 |
| Trading at (% of 52 Week High) | 71.43% |
Alcidion Group Limited (ASX: ALC) is a technology company that provides clinical decision support and patient flow management solutions for healthcare providers. Their platform integrates data to help improve patient outcomes and operational efficiency in hospitals and health systems. The company operates primarily in Australia and internationally.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for ALCIDION GROUP LIMITED is supported by current price weakness and negative AI signal, indicating potential downside risk. However, the relatively low price level suggests some volatility and market sensitivity, warranting a high but not very high confidence level.
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.
Alcidion Group’s fair value estimate is set at A$0.14 and remains unchanged in the latest update, even as underlying model inputs have been fine tuned. That stability lines up with recent sec Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Alcidion Group’s fair value price target is held at A$0.1425, with no change to the underlying valuation in the latest model refresh. This steady A$0.14 anchor reflects sector com Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Alcidion Group’s A$0.14 price target is being held steady, with the unchanged A$0.1425 fair value reinforcing that analysts are Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide.
Alcidion Group’s fair value price target is held steady at A$0.14667, with the latest work keeping it aligned with the prior A$0.15 view. This reflects a sec The Australian market is currently experiencing a wave of mergers and acquisitions, with significant attention on potential deals involving major players like BlueScope Steel and Rio Tinto. Amidst these high-profile movements, investors may find opportunities in penny stocks, a term that, while someLatest ALCIDION GROUP LIMITED(ALC) News
How The Alcidion Group (ASX:ALC) Story Is Evolving As Guidance And Valuation Converge
Why The Story Around Alcidion Group (ASX:ALC) Is Evolving While Fair Value Stays Steady
How The Alcidion Group (ASX:ALC) Story Is Evolving With A Steady A$0.14 Target
How A Mixed Sector Backdrop Is Shaping The Evolving Story For Alcidion Group (ASX:ALC)
ASX Penny Stocks To Watch With Market Caps Larger Than A$100M
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial